Consolidated Statements of Financial Position | Financial Information | Investor Relations

Consolidated Statements of Financial Position (Consolidated Balance Sheets)　Full Year （36KB）

（Millions of Yen）

	2019/3	2020/3	2021/3~{1,2}	2022/3	2023/3	2024/3	2025/3	2026/3
Asset
Cash and Cash Equivalents	546,784	880,100	1,065,726	1,127,523	1,651,851	1,420,430	1,043,944	1,068,032
Call Loans for Banking Business	20,000	-	65,000	80,000	98,000	116,082	63,000	52,788
Trade and Other Receivables	328,281	386,799	480,195	368,618	623,300	684,011	673,275	539,360
Inventories	18,306	20,889	24,668	26,671	31,690	35,028	32,436	32,335
Loans for Credit Card Business	253,340	342,245	407,955	475,528	593,058	783,869	983,790	1,252,928
Investment Securities for Banking Business	419,551	415,809	517,984	464,145	414,719	655,075	908,887	1,550,844
Loans for Banking Business	80,942	98,752	247,047	414,620	620,383	723,167	926,334	1,615,955
Other Financial Assets	191,260	264,213	448,210	511,487	447,841	456,812	398,510	714,667
Property and Equipment	133,867	131,215	150,478	164,783	213,839	238,399	262,172	259,634
Right-of-use Assets	-	106,304	150,928	162,763	221,221	189,292	178,673	198,026
Goodwill	175,301	400,034	1,790,487	1,788,481	2,074,779	2,067,862	2,073,470	2,191,690
Intangible Assets	165,293	679,375	1,061,780	1,216,379	1,267,738	1,248,923	1,233,421	1,309,654
Investments Accounted for Using the Equity Method	24,510	8,567	177,650	203,398	191,048	240,342	265,599	192,262
Deferred Tax Assets	34,551	43,739	39,427	37,176	44,477	29,030	44,238	119,529
Other Assets	37,609	155,863	63,788	68,806	94,772	155,640	70,592	107,481
Subtotal	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346	11,205,191
Assets classified as held-for-sale	-	-	-	-	-	-	-	-
Total Assets	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346	11,205,191

（Millions of Yen）

	2019/3	2020/3	2021/3~{1,2}	2022/3	2023/3	2024/3	2025/3	2026/3
Liabilities
Trade and Other Payables	394,545	589,342	616,681	524,989	1,351,794	1,551,611	1,712,145	2,218,513
Deposits for Banking Business	768,613	903,118	1,186,206	1,431,175	1,495,629	1,672,746	1,830,293	2,701,160
Interest-bearing Liabilities	215,212	1,086,436	1,389,563	1,666,503	1,913,799	1,882,752	1,694,398	1,961,998
Other Financial Liabilities	8,683	10,157	10,759	8,528	14,729	27,054	26,610	92,274
Income Taxes Payable	24,138	32,887	47,024	43,186	31,616	38,361	50,060	43,127
Provisions	30,360	28,161	33,075	28,619	23,136	25,630	29,544	37,180
Deferred Tax Liabilities	20,403	160,976	278,216	262,539	240,772	190,614	188,084	191,944
Other Liabilities	57,118	75,006	140,203	162,645	199,345	208,211	208,293	245,482
Subtotal	1,519,077	2,886,086	3,701,730	4,128,188	5,270,822	5,596,983	5,739,431	7,491,682
Liabilities directly associated with assets classified as held for sale	-	-	-	-	-	-	-	-
Total Liabilities	1,519,077	2,886,086	3,701,730	4,128,188	5,270,822	5,596,983	5,739,431	7,491,682

Equity
Equity Attributable to Owners of the Parent
Common Stock	8,939	237,422	237,724	237,980	247,094	248,144	250,128	252,134
Capital Surplus	(12,545)	212,539	2,063,881	2,037,384	2,046,696	2,060,766	1,880,031	1,699,597
Retained Earnings	832,147	330,752	362,999	401,322	647,347	723,884	838,017	996,061
Treasury Stock	(24,440)	(17,382)	(17,385)	(54,086)	(70,436)	(70,037)	(11,704)	(13,338)
Accumulated Other Comprehensive Income	14,190	8,216	35,098	61,776	48,697	74,329	41,696	64,350
Total Equity Attributable to Owners of the Parent	818,291	771,548	2,682,318	2,684,377	2,919,399	3,037,088	2,998,170	2,998,805
Non-controlling Interests	92,231	276,274	307,279	297,819	398,501	409,897	420,745	714,704
Total Equity	910,523	1,047,823	2,989,597	2,982,197	3,317,900	3,446,985	3,418,915	3,713,509
Total Liabilities and Equity	2,429,601	3,933,910	6,691,328	7,110,386	8,588,722	9,043,969	9,158,346	11,205,191

Notes

The consolidated financial statements of the fiscal year ended March 31, 2021 have been retroactively revised with the finalization of the provisional accounting made in the consolidated second quarter of the fiscal year ending March 31, 2022 in connection with the business combination.
In FY2021-Q3, recorded impairment loss on investments in associates and joint ventures of ¥18.3 billion due to the reduction of the carrying amount of the investment accounted for using the equity method with regard to Demae-can Co., Ltd., to the recoverable amount.